Skip to main content
Clinical Trials/NCT05567744
NCT05567744
Recruiting
Not Applicable

Research Registry for Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

University of Wisconsin, Madison1 site in 1 country2,500 target enrollmentJune 3, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy
Sponsor
University of Wisconsin, Madison
Enrollment
2500
Locations
1
Primary Endpoint
A Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Registry
Status
Recruiting
Last Updated
6 months ago

Overview

Brief Summary

This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL or are at risk. Participation means that your name will be added to a list of people who will be invited to participate in future research studies on CADASIL. Participants must be 18 years or older, and will remain on the registry until they request to be removed.

Detailed Description

The purpose of this registry is to allow Dr. Jane Paulsen and her CADASIL research teams to contact individuals on the list who may fit a study's eligibility requirements. All individuals interested in CADASIL research who either have a family member or loved one, or are at risk themselves, are eligible to participate in this registry. Information collected as part of the registry will be used solely to determine potential participant's eligibility to participate research. A patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose(s).

Registry
clinicaltrials.gov
Start Date
June 3, 2022
End Date
October 1, 2027
Last Updated
6 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • have a loved one or a family member with CADASIL, or are at-risk for CADASIL themselves

Exclusion Criteria

  • Under 18 years of age

Outcomes

Primary Outcomes

A Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Registry

Time Frame: Up to 20 years

Create a list of persons willing to volunteer for CADASIL-related research to facilitate efficient recruitment.

Study Sites (1)

Loading locations...

Similar Trials